Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-07 12:16 pm Sale | 2023-12-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | BML Investment Partners, L.P. | 50,000 0.100% | -3,287,774 (-98.50%) | Filing History |
| 2024-02-07 11:53 am Purchase | 2023-12-31 | 13G | CLIMB BIO, INC. CLYM | BML Investment Partners, L.P. | 2,350,682 8.500% | 453,068 (+23.88%) | Filing History |
| 2024-02-07 11:36 am Sale | 2023-12-31 | 13G | ADVERUM BIOTECHNOLOGIES INC CO ADVM | BML Investment Partners, L.P. | 485,425 2.300% | -244,593 (-33.51%) | Filing History |
| 2024-02-07 11:14 am Purchase | 2023-12-31 | 13G | CALCIMEDICA INC CALC | BML Investment Partners, L.P. | 44,085 2.100% | 26,429 (+149.69%) | Filing History |
| 2024-02-07 10:50 am Sale | 2023-12-31 | 13G | QUINCE THERAPEUTICS, INC QNCX | BML Investment Partners, L.P. | 0 0.000% | -9,207 (Position Closed) | Filing History |
| 2024-02-07 10:32 am Purchase | 2024-02-07 | 13G | AVROBIO INC AVRO | BML Investment Partners, L.P. | 366,802 9.900% | 36,352 (+11.00%) | Filing History |
| 2024-02-07 09:25 am Unchanged | 2023-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners, L.P. | 5,602,079 6.700% | 0 (Unchanged) | Filing History |
| 2024-02-07 09:14 am Purchase | 2023-12-31 | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners, L.P. | 5,602,079 6.700% | 1,418,434 (+33.90%) | Filing History |
| 2024-01-16 5:54 pm Purchase | 2024-01-10 | 13G | RENEO PHARMACEUTICALS INC RPHM | BML Investment Partners, L.P. | 169,423 5.100% | 169,423 (New Position) | Filing History |
| 2024-01-16 5:24 pm Purchase | 2024-01-11 | 13G | ACLARIS THERAPEUTICS INC ACRS | BML Investment Partners, L.P. | 4,500,000 6.400% | 4,500,000 (New Position) | Filing History |
| 2024-01-10 5:39 pm Purchase | 2024-01-10 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners, L.P. | 70,468 4.800% | 1,065 (+1.53%) | Filing History |
| 2023-11-24 11:33 am Purchase | 2023-11-13 | 13G | RAIN ONCOLOGY INC. RAIN | BML Investment Partners, L.P. | 1,815,953 6.600% | 1,815,953 (New Position) | Filing History |
| 2023-10-02 11:45 am Purchase | 2023-09-25 | 13G | ATEA PHARMACEUTICALS INC AVIR | BML Investment Partners, L.P. | 4,183,645 5.000% | 4,183,645 (New Position) | Filing History |
| 2023-09-15 12:00 pm Unchanged | 2023-09-15 | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners, L.P. | 69,403 4.780% | 0 (Unchanged) | Filing History |
| 2023-07-24 3:23 pm Purchase | 2023-07-13 | 13G | AVROBIO INC AVRO | BML Investment Partners, L.P. | 330,450 9.000% | 330,450 (New Position) | Filing History |
| 2023-07-17 11:07 am Purchase | 2023-07-06 | 13G | QUINCE THERAPEUTICS, INC QNCX | BML Investment Partners, L.P. | 9,207 5.070% | 9,207 (New Position) | Filing History |
| 2023-06-26 4:00 pm Unchanged | 2023-06-26 | 13D | ASTROTECH CORP COM PAR $ ASTC | BML Investment Partners, L.P. | 232,065 13.700% | 0 (Unchanged) | Filing History |
| 2023-06-12 6:57 pm Sale | 2023-06-08 | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | BML Investment Partners, L.P. | 0 0.000% | -6,590,000 (Position Closed) | Filing History |
| 2023-04-27 2:19 pm Unchanged | 2023-04-17 | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners, L.P. | 218,919 5.200% | 0 (Unchanged) | Filing History |
| 2023-04-27 10:55 am Purchase | 2023-04-17 | 13G | TALARIS THERAPEUTICS INC TALS | BML Investment Partners, L.P. | 218,919 5.200% | 218,919 (New Position) | Filing History |